If you have dry age-related macular degeneration, your central vision may end up blurry, distorted or dim.

Discover the latest breakthroughs in the fight against dry, age-related macular degeneration. Learn about the first approved ...

Full 12-month data from Ocugen’s phase 2 eye disease gene therapy show the therapy significantly reduces the size of lesions, ...

"This is the first economic modeling study in late-stage age-related macular degeneration (AMD) that extends beyond traditional cost analyses to include the impact on well-being and productivity and ...

Add Yahoo as a preferred source to see more of our stories on Google. USC Roski Eye Institute researchers are launching a phase 2b trial of a stem cell retinal implant designed to replace damaged ...

A new study suggests that measuring specific immune system proteins in the blood could help predict which patients with intermediate age-related macular degeneration (AMD) are most likely to progress ...

AI-powered wearable glasses empower individuals living with age-related macular degeneration (AMD) and other retinal ...

Toll-like receptors, or TLRs, are the immune system’s early warning sensors. They detect microbial invaders and damage signals, helping the body mount a defense. But when TLR signaling veers off ...

Optimal dose intended for Phase 3 demonstrates statistically significant reduction in lesion growth (31%) versus control at 12 months (p< ...

March 20 () - EyePoint filed a lawsuit on Friday accusing rival Ocular Therapeutix of spreading false or ‌misleading ...

Judi Dench-the Academy Award-winning film and stage actress known for her iconic portrayal of M, head of MI6, in the James Bond franchise-said earlier this month on the podcast “Fearless” that someone ...